Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -58.430% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CCC(C)c1ccc(NC(=O)CN(C)CC(=O)Nc2cccc(OC)c2)cc1
(b) Cc1cc(N2CCN(C)CC2)nc2ccc(NC(=O)c3ccccc3F)cc12
Answer: b. Cc1cc(N2CCN(C)CC2)nc2ccc(NC(=O)c3ccccc3F)cc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(N2CCN(C)CC2)nc2ccc(NC(=O)c3ccccc3F)cc12
Cc1cc(N2CCN(C)CC2)nc2ccc(NC(=O)c3ccccc3F)cc12
2-fluoro-N-[4-methyl-2-(4-methylpiperazin-1-yl)quinolin-6-yl]benzamide